ALTS - ALT5 Sigma Corp
1.4
-0.020 -1.429%
Share volume: 1,484,140
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.42
-0.02
-0.01%
View ratios
| Fiscal Date | 03-29-2025 | 06-28-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | |
| Report Date | 05-13-2025 | 08-12-2025 | |
| Total revenue | 5.514 M | 6.378 M | |
| Cost of revenue | 2.923 M | 3.603 M | |
| Gross profit | 2.591 M | 2.775 M | |
| 7.10% | |||
| Operating expenses | 4.761 M | 4.870 M | |
| Selling general and admin | 4.761 M | 4.870 M | |
| Research and development | 0.000 | 0.000 | |
| Total expenses | 4.761 M | 4.870 M | |
| 2.29% | |||
| Operating income | -2.170 M | -2.095 M | |
| Ebit | 0.000 | 0.000 | |
| Pretax income | -2.576 M | -5.934 M | |
| 130.36% | |||
| Income tax | 285.000 K | -432.000 K | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -2.861 M | -9.115 M | |
| -218.59% |